Duncan Williams Upgrades Cumberland Pharmaceuticals (CPIX) to Hold; New Formulation Buys Time
Tweet Send to a Friend
Duncan Williams upgraded Cumberland Pharmaceuticals (NASDAQ: CPIX) from Reduce to Hold.
Duncan analyst says, "We believe a generic overhang still ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Duncan analyst says, "We believe a generic overhang still ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
